X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (37293) 37293
Publication (2524) 2524
Newsletter (2476) 2476
Book Chapter (413) 413
Book Review (403) 403
Conference Proceeding (234) 234
Newspaper Article (222) 222
Magazine Article (93) 93
Dissertation (85) 85
Reference (44) 44
Book / eBook (33) 33
Web Resource (10) 10
Government Document (8) 8
Transcript (6) 6
Data Set (4) 4
Trade Publication Article (2) 2
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (18613) 18613
humans (14413) 14413
male (13637) 13637
rats (10280) 10280
neurosciences (8298) 8298
monoamine oxidase (7855) 7855
female (7438) 7438
index medicus (7212) 7212
monoamine oxidase - metabolism (6208) 6208
pharmacology & pharmacy (5645) 5645
monoamine oxidase inhibitors - pharmacology (4663) 4663
mice (4191) 4191
serotonin (4169) 4169
dopamine (4084) 4084
psychiatry (3864) 3864
adult (3693) 3693
brain (3299) 3299
serotonin - metabolism (3278) 3278
dopamine - metabolism (3148) 3148
biochemistry & molecular biology (3106) 3106
brain - metabolism (3069) 3069
research (2898) 2898
monoamine-oxidase (2865) 2865
middle aged (2823) 2823
biogenic monoamines - metabolism (2610) 2610
monoamines (2427) 2427
monoamine oxidase inhibitors - therapeutic use (2389) 2389
monoamine oxidase inhibitors (2225) 2225
clinical neurology (2214) 2214
brain - drug effects (2095) 2095
analysis (2047) 2047
rats, sprague-dawley (2043) 2043
brain - enzymology (1946) 1946
norepinephrine - metabolism (1946) 1946
dose-response relationship, drug (1916) 1916
depression (1894) 1894
kinetics (1849) 1849
time factors (1829) 1829
parkinson's disease (1804) 1804
aged (1794) 1794
in vitro techniques (1709) 1709
rats, wistar (1642) 1642
parkinsons-disease (1635) 1635
monoamine oxidase - blood (1476) 1476
monoamine oxidase - genetics (1457) 1457
norepinephrine (1409) 1409
neurons (1404) 1404
rats, inbred strains (1398) 1398
rat-brain (1363) 1363
chemistry, medicinal (1352) 1352
article (1278) 1278
antidepressants (1266) 1266
rat (1260) 1260
adolescent (1193) 1193
enzymes (1152) 1152
physiological aspects (1149) 1149
oxidative stress (1133) 1133
behavior (1119) 1119
neurology (1092) 1092
antidepressive agents - therapeutic use (1072) 1072
disease models, animal (1072) 1072
reports (1064) 1064
monoamine oxidase inhibitors - adverse effects (1061) 1061
metabolism (1053) 1053
monoamine (1052) 1052
motor activity - drug effects (1043) 1043
toxicology (1036) 1036
behavior, animal - drug effects (1029) 1029
monoamine oxidase - analysis (1027) 1027
drug interactions (999) 999
blood platelets - enzymology (997) 997
depressive disorder - drug therapy (984) 984
antidepressive agents - pharmacology (977) 977
liver - enzymology (949) 949
structure-activity relationship (947) 947
corpus striatum - metabolism (924) 924
drugs (905) 905
universities and colleges (901) 901
brain chemistry - drug effects (894) 894
mice, inbred c57bl (893) 893
inhibition (890) 890
metabolites (874) 874
noradrenaline (873) 873
neurons - metabolism (870) 870
selegiline - pharmacology (863) 863
pregnancy (855) 855
pharmacology (844) 844
cell biology (831) 831
behavioral sciences (824) 824
chromatography, high pressure liquid (824) 824
parkinson disease - drug therapy (820) 820
genetic aspects (789) 789
phenols (789) 789
expression (784) 784
receptors (781) 781
stress (781) 781
neurotransmitters (776) 776
alzheimer's disease (774) 774
neurons - drug effects (758) 758
schizophrenia (756) 756
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (37090) 37090
Russian (1082) 1082
French (663) 663
German (539) 539
Japanese (442) 442
Chinese (183) 183
Polish (172) 172
Spanish (160) 160
Italian (82) 82
Portuguese (37) 37
Swedish (37) 37
Czech (33) 33
Hungarian (32) 32
Ukrainian (31) 31
Korean (27) 27
Danish (15) 15
Dutch (15) 15
Finnish (15) 15
Bulgarian (11) 11
Norwegian (9) 9
Turkish (9) 9
Serbian (4) 4
Slovak (3) 3
Croatian (2) 2
Hebrew (2) 2
Slovenian (2) 2
Georgian (1) 1
Indonesian (1) 1
Lithuanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Naunyn-Schmiedeberg's Archives of Pharmacology, ISSN 0028-1298, 1/2017, Volume 390, Issue 1, pp. 15 - 24
3,4-Methylenedioxy-N-methylamphetamine (MDMA) has been shown to be effective in the treatment of post-traumatic stress disorder (PTSD) in numerous clinical... 
Neurosciences | Biomedicine | Monoamine receptors | Neurochemical profile | MDMA analogues | Monoamine transporters | Pharmacology/Toxicology | 3,4-Methylenedioxy- N -methylamphetamine (MDMA) | 3,4-Methylenedioxy-N-methylamphetamine (MDMA) | POSTTRAUMATIC-STRESS-DISORDER | NICOTINIC RECEPTORS | NOREPINEPHRINE | ECSTASY | DRUGS | DOPAMINE | PHARMACOLOGY & PHARMACY | 3,4-METHYLENEDIOXYMETHAMPHETAMINE-ASSISTED PSYCHOTHERAPY | SEROTONIN | INDUCED NEUROTOXICITY | UP-REGULATION | Tyrosine 3-Monooxygenase - metabolism | Vesicular Monoamine Transport Proteins - metabolism | Receptors, Serotonin, 5-HT2 - chemistry | Stress Disorders, Post-Traumatic - metabolism | Humans | Neurotransmitter Uptake Inhibitors - pharmacology | Benzofurans - pharmacology | Serotonin 5-HT2 Receptor Agonists - pharmacology | Receptors, Serotonin, 5-HT2 - drug effects | Structure-Activity Relationship | Receptors, Serotonin, 5-HT2 - metabolism | Neurotransmitter Uptake Inhibitors - metabolism | Benzofurans - chemistry | Catechol O-Methyltransferase - metabolism | Monoamine Oxidase - chemistry | Indoles - metabolism | Tyrosine 3-Monooxygenase - chemistry | N-Methyl-3,4-methylenedioxyamphetamine - pharmacology | Stress Disorders, Post-Traumatic - drug therapy | Indoles - pharmacology | N-Methyl-3,4-methylenedioxyamphetamine - chemistry | Radioligand Assay | Serotonin 5-HT2 Receptor Agonists - metabolism | Binding Sites | Monoamine Oxidase Inhibitors - pharmacology | Vesicular Monoamine Transport Proteins - chemistry | Vesicular Monoamine Transport Proteins - antagonists & inhibitors | Serotonin 5-HT2 Receptor Agonists - chemistry | N-Methyl-3,4-methylenedioxyamphetamine - metabolism | Neurotransmitter Uptake Inhibitors - chemistry | Monoamine Oxidase Inhibitors - metabolism | Protein Binding | Protein Conformation | Monoamine Oxidase Inhibitors - chemistry | Catechol O-Methyltransferase - chemistry | Indoles - chemistry | Benzofurans - metabolism | Monoamine Oxidase - metabolism | Monoamine oxidase | Batteries | Methamphetamine | Ecstasy (Drug) | Resveratrol | Post-traumatic stress disorder | Index Medicus
Journal Article
European Journal of Medicinal Chemistry, ISSN 0223-5234, 10/2016, Volume 121, pp. 864 - 879
Currently available drugs against Alzheimer's disease (AD) are only able to ameliorate the disease symptoms resulting in a moderate improvement in memory and... 
Human acetylcholinesterase | MAO-A | Molecular modeling | Human butyrylcholinesterase | Metal chelating properties | ADME+T properties | Antioxidant properties | MAO-B | Alzheimer's disease | Molecular docking | CHEMISTRY, MEDICINAL | ALZHEIMERS-DISEASE | CHOLINESTERASE-INHIBITORS | SEROTONIN 5-HT1A | DRUGS | POTENTIAL TREATMENT | NITRIC-OXIDE | FORCE-FIELD | OXIDASE-INHIBITORS | ADME plus T properties | RATIONAL DESIGN | HYBRIDS | Antioxidants - chemistry | Antioxidants - metabolism | Humans | Structure-Activity Relationship | Monoamine Oxidase Inhibitors - chemical synthesis | Monoamine Oxidase - chemistry | Piperidines - pharmacology | Drug Design | Indans - chemistry | Monoamine Oxidase Inhibitors - pharmacology | Piperidines - chemistry | Chemistry Techniques, Synthetic | Piperidines - metabolism | Chelating Agents - chemistry | Indans - metabolism | Acetylcholinesterase - chemistry | Antioxidants - chemical synthesis | Antioxidants - pharmacology | Chelating Agents - pharmacology | Piperidines - chemical synthesis | Monoamine Oxidase Inhibitors - metabolism | Indans - chemical synthesis | Protein Conformation | Molecular Docking Simulation | Monoamine Oxidase Inhibitors - chemistry | Chelating Agents - chemical synthesis | Chelating Agents - metabolism | Acetylcholinesterase - metabolism | Indans - pharmacology | Monoamine Oxidase - metabolism | Antioxidants | Enzymes | Monoamine oxidase | Analysis | Models | Drug discovery | Target marketing
Journal Article
ChemMedChem, ISSN 1860-7179, 06/2016, Volume 11, Issue 12, pp. 1264 - 1269
Novel indolotacrine analogues were designed, synthesized, and evaluated as potential drugs for the treatment of Alzheimer's disease. By using a... 
inhibitors | multitarget-directed ligands | cholinesterases | Alzheimer's disease | cytotoxicity | monoamine oxidase | MONOAMINE-OXIDASE | OXIDATIVE STRESS | CHEMISTRY, MEDICINAL | MULTIPOTENT | DONEPEZIL | CHOLINERGIC HYPOTHESIS | POTENTIAL TREATMENT | PHARMACOLOGY & PHARMACY | CHOLINESTERASE/MONOAMINE OXIDASE-INHIBITORS | PHARMACOLOGICAL EVALUATION | AGGREGATION | HYBRIDS | Cholinesterase Inhibitors - toxicity | Humans | Indoles - chemical synthesis | Cholinesterase Inhibitors - chemical synthesis | Structure-Activity Relationship | Monoamine Oxidase Inhibitors - chemical synthesis | Tacrine - therapeutic use | Monoamine Oxidase - chemistry | Indoles - metabolism | Cholinesterase Inhibitors - metabolism | Drug Design | Inhibitory Concentration 50 | Quinolines - toxicity | Tacrine - chemistry | Monoamine Oxidase Inhibitors - therapeutic use | Cell Survival - drug effects | Tacrine - metabolism | Quinolines - chemistry | Alzheimer Disease - drug therapy | Indoles - toxicity | Acetylcholinesterase - chemistry | Blood-Brain Barrier - metabolism | Hep G2 Cells | Quinolines - chemical synthesis | Quinolines - metabolism | Monoamine Oxidase Inhibitors - toxicity | Monoamine Oxidase Inhibitors - metabolism | Indoles - therapeutic use | Ligands | Quinolines - therapeutic use | Cholinesterase Inhibitors - therapeutic use | Indoles - chemistry | Acetylcholinesterase - metabolism | Monoamine Oxidase - metabolism | Tacrine - toxicity | Antioxidants | Monoamine oxidase | Permeability | Drug therapy | Analysis | Index Medicus
Journal Article
Nature Medicine, ISSN 1078-8956, 2014, Volume 20, Issue 8, pp. 886 - 896
In Alzheimer's disease (AD), memory impairment is the most prominent feature that afflicts patients and their families. Although reactive astrocytes have been... 
MEDICINE, RESEARCH & EXPERIMENTAL | GLUTAMATE RELEASE | BIOCHEMISTRY & MOLECULAR BIOLOGY | MAO-B | CELL BIOLOGY | PUTRESCINE | CHANNEL | MONOAMINE-OXIDASE-B | SELEGILINE | CULTURED ASTROCYTES | L-DEPRENYL | MICE | DENTATE GYRUS | Memory - drug effects | RNA, Small Interfering - genetics | Alzheimer Disease - complications | Amyloid beta-Peptides - pharmacology | Humans | Ion Channels - genetics | Memory Disorders - metabolism | Male | Peptide Fragments - pharmacology | Monoamine Oxidase - genetics | GABA Antagonists - therapeutic use | Bestrophins | Eye Proteins - genetics | Putrescine - pharmacology | Disease Models, Animal | Astrocytes - drug effects | Monoamine Oxidase Inhibitors - pharmacology | Dentate Gyrus - metabolism | Cerebellum - metabolism | Mice, Inbred C57BL | Alzheimer Disease - drug therapy | Mice, Transgenic | Hippocampus - cytology | Mice, Inbred ICR | Hippocampus - metabolism | Amyloid Precursor Protein Secretases - metabolism | Animals | Maze Learning | Memory Disorders - drug therapy | Memory Disorders - etiology | Eye Proteins - metabolism | Ion Channels - metabolism | gamma-Aminobutyric Acid - biosynthesis | Alzheimer Disease - metabolism | Receptors, GABA - metabolism | Plaque, Amyloid - metabolism | Mice | Astrocytes - metabolism | Monoamine Oxidase - metabolism | Care and treatment | Monoamine oxidase | Analysis | Physiological aspects | GABA | Diagnosis | Alzheimer's disease | Risk factors | Models | Alzheimers disease | Memory | Rodents
Journal Article
Journal Article